| Gene symbol | IFNA2 | Synonyms | IFN-alpha-2, IFN-alphaA, IFNA, IFNA2B, leIF A | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9p21.3 | dbXrefs | |
| Description | interferon alpha 2 | ||||
| GTO ID | GTC0102 |
| Trial ID | NCT01212367 |
| Disease | Malignant Pleural Mesothelioma |
| Altered gene | IFNA2 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | SCH 721015 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Pilot Study of Repeated Dose Intrapleural Adenoviral-Mediated Interferon-Alpha (SCH 721015, Ad.HIFN-a2b) Gene Transfer for Malignant Pleural Mesothelioma |
| Year | 2010 |
| Country | United States |
| Company sponsor | Abramson Cancer Center at Penn Medicine |
| Other ID(s) | UPCC 18508; 808806|P01CA066726 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort1: dose level 1 | |||||||||||||
|
|||||||||||||
| Cohort2: dose level 2 | |||||||||||||
|
|||||||||||||